---
title: "RS BioTherapeutics Inc. SEC filings"
url: https://altstreet.investments/edgar/1932193
kind: edgar-entity
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# RS BioTherapeutics Inc.: SEC filings and what they report

| Field | Value |
| --- | --- |
| Entity | RS BioTherapeutics Inc. |
| CIK | 1932193 |
| Filing family | Form C |

## Filings (11 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| September 23, 2026 | C-TR | Form C | https://www.sec.gov/Archives/edgar/data/1932193/000193219326000005/ |
| September 23, 2026 | C-AR | Form C | https://www.sec.gov/Archives/edgar/data/1932193/000193219326000004/ |
| May 2, 2025 | C-AR | Form C | https://www.sec.gov/Archives/edgar/data/1932193/000166516025000955/ |
| October 9, 2024 | D | Form D | https://www.sec.gov/Archives/edgar/data/1932193/000193219324000001/ |
| September 6, 2024 | C-U | Form C | https://www.sec.gov/Archives/edgar/data/1932193/000166516024001291/ |
| May 22, 2024 | C/A | Form C | https://www.sec.gov/Archives/edgar/data/1932193/000166516024000900/ |
| April 29, 2024 | C | Form C | https://www.sec.gov/Archives/edgar/data/1932193/000166516024000649/ |
| October 19, 2023 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1932193/000193219323000003/ |
| August 10, 2023 | D | Form D | https://www.sec.gov/Archives/edgar/data/1932193/000193219323000002/ |
| March 22, 2023 | D | Form D | https://www.sec.gov/Archives/edgar/data/1932193/000193219323000001/ |
| June 21, 2022 | D | Form D | https://www.sec.gov/Archives/edgar/data/1932193/000193219322000001/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/1932193
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001932193&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/1932193
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.
